Articles from Vibrent Health

Vibrent Health, a leading software-as-a-service (SaaS) data company in the field of precision medicine research, is collaborating with Fred Hutch Cancer Center (Fred Hutch) under a $17 million contract awarded through the Biomedical Advanced Research and Development Authority’s (BARDA) Rapid Response Partnership Vehicle (RRPV) Consortium. This collaboration drives critical research on correlates of protection (CoPs), which are measurable immune markers predicting protective immunity against disease, through decentralized clinical trials (DCTs).

Vibrent Health, the leading digital platform for next-generation person-centered health research, is pleased to announce the launch of the Genomics REsearch Advancing Transformational (GREAT) Health Study at Meharry Medical College.

Vibrent Health, the leading digital platform for next-generation precision health research, today announced that its Digital Health Research Cloud for Government has received a Federal Risk and Authorization Management Program (FedRAMP®) Moderate Authority to Operate (ATO) and is now available on the FedRAMP Marketplace. This authorization affirms that Vibrent meets rigorous NIST 800-53 standards and HIPAA compliance requirements, including encryption, continuous monitoring, incident response, and privacy safeguards for protected health information (PHI) and personally identifiable information (PII) and other data.

Vibrent Health, a leading software-as-a-service company in the field of precision genomics research, announced today the creation of the largest research dataset of individuals identifying as LGBTQIA+. Vibrent's technology collaboration with the National Institutes of Health (NIH) All of Us Research Program facilitated this historic milestone.

Today, just one in every thousand people in the United States reaches the age of 95 or older. While lifestyle may be a factor, researchers believe there could be genetic drivers that influence whether an individual lives an exceptionally long life.

Vibrent Health, a leading software-as-a-service company in the field of precision health research, announced today the publication of a methods paper in JMIR Formative Research (JFR). The prospective cohort study is titled A Digital Health Initiative (COVIDsmart) for Remote Data Collection and Study of COVID-19’s Impact on the State of Virginia.

Vibrent Health, a digital technology company known for its innovation in precision medicine research solutions and its expertise in building human cohorts, announces the launch of a new podcast featuring leaders in precision health and population genomics research.

Multiple myeloma is a cancer of the plasma cells in bone marrow that affects more than 30,000 new patients in the United States each year. Today, multiple myeloma is still considered incurable.

Vibrent Health, a health technology startup, is helping researchers recruit and engage people with disabilities in research by ensuring that digital health research tools the company develops support people with disabilities and comply with government rules for accessibility. Making digital health technology products that accommodate people with disabilities can help researchers reach their inclusion goals and obtain more complete data by including diverse participants. Recruiting diverse individuals has become increasingly important in health research and can be a prerequisite for research sponsorship and funding.

Vibrent Health, a health technology startup powering the future of precision health research, today announced that the company’s Digital Health Research Platform will serve as the technology backbone of My Healthy Maryland Precision Medicine Research, a joint initiative of the University of Maryland School of Medicine and the University of Maryland Medical Center and Medical System. The project launched on June 21 and aims to enroll 250,000 diverse Maryland residents over the next decade.

More than 8 million infections of COVID-19 could be prevented by using digital tools for screening and testing of infectious diseases, according to a study conducted by Virginia Commonwealth University (VCU) and Vibrent Health, a health technology startup powering the future of precision medicine research. Funded by National Institutes of Health (NIH) as part of its RADx program, Vibrent Health developed a digital screening and testing tool that uses more than 4 million datapoints to determine an individual’s risk factor for COVID-19. The study showed that the online screening method was easily accessible to diverse and underserved populations and that computerized screening could be effective in stopping the spread of COVID-19 and other infectious diseases.

The National Institutes of Health’s All of Us Research Program has made its initial genomic dataset available, bringing nearly 100,000 whole genome sequences from diverse participants, including nearly 50% of participants self-identifying with minority racial and ethnic groups, onto its data analysis platform, the Researcher Workbench. Vibrent Health, a health technology startup powering the future of precision medicine research, serves as the Participant Technology Systems Center for All of Us and has played a major role in this milestone, providing tools to build relationships between program partners and study participants as well as providing the critical digital infrastructure needed to drive recruitment and engagement.

Vibrent Health, a digital health technology startup dedicated to powering the future of precision health research, announced a rebranding of their participant-facing digital health research portal and mobile apps, formerly the Participant Portal, as the Participant Cloud. Researchers use the Participant Cloud, which is part of Vibrent Health’s Digital Health Solutions Platform, to remotely recruit and engage participants and collect health data from broad sources for decentralized health research.

Vibrent Health, a health technology startup powering the future of precision health research, announced the integration of electronic health record (EHR) data into its Digital Health Solutions Platform, a platform that enables collection of health data from broad sources including biospecimens, genomics, environment, lifestyle and behavior, and wearable device data for clinical research and trials. Vibrent Health supports leading FHIR-enabled EHR vendors such as Epic and Cerner to ensure that their systems are seamlessly interoperable with the DHS Platform.

Vibrent Health, a health technology startup powering the future of precision health research, has developed artificial-intelligence-enabled technology which can greatly improve public health pandemic preparedness and response. The AI-driven privacy-preserving virtual symptom screening application, BASIS (Broad Assessment and Symptom Identification System), offers a flexible and convenient way to screen and test people who experience symptoms of COVID-19 or other respiratory infections. It also allows users to activate optional contact tracing if they get a positive result.

Today Vibrent Health announced the launch of a Global Twin Research Platform (GTRP), in partnership with the Virginia Commonwealth University (VCU), to better understand health similarities and differences between twins by studying the varying genetic and environmental influences on development, including physical development, intelligence, emotion and cognition.

Vibrent Health, a health technology company powering the future of precision medicine, announced the successful launch of its Clinical Research Board (CRB), which serves as a valuable forum for the health research ecosystem to inform Vibrent Health’s technology roadmap. The board’s role is to help shape the digital health tools of the future to the benefit of the research community at large.

Vibrent Health, a health technology company powering the future of precision health research, today announced the company has integrated advanced computer-assisted telephone interviewing (A-CATI) into its ground-breaking Digital Health Solutions (DHS) Platform.

The National Institutes of Health’s (NIH) National Cancer Institute (NCI) has awarded Vibrent Health, a digital health technology company powering the future of precision health research, the second phase of a contract to validate COVID-CARE, a digital health solution for pandemic response. The web and mobile application will enable fast and accurate screening, automated test kit shipping, and contact tracing for COVID-19 and other infectious diseases. Vibrent Health built the web-based and mobile application on its versatile Digital Health Solutions Platform, which also serves as the consumer-facing technology platform of the one-million person NIH All of Us Research Program.

Today Vibrent Health announced a collaboration with Virginia Commonwealth University to support its digital research capabilities to streamline how researchers across the university collect, manage, share and utilize data.